mRNA Flu Vaccine Study

About This Research Study 

Influenza (flu) is an infectious disease characterized by the abrupt onset of respiratory and systemic symptoms, such as fever, cough, sore throat, and rhinitis. Research studies are crucial, especially for developing vaccines to protect children, seniors, and people with underlying medical conditions. 

Most flu vaccines are generated in embryonated hens’ eggs or in cell lines. In this study, researchers are studying a whether an investigational mRNA vaccine could be an effective alternative to traditional flu vaccine approaches. Meridian is now seeking participants for this study. 

Eligible participants… 

• Must be age 18 or older
• Can NOT have a history of myocarditis, pericarditis, and/or myopericarditis 
• Must NOT have received an influenza vaccine within the past 6 months, an mRNA vaccine in the past 2 months, or any other vaccines in the last month 
• Will receive either an investigational mRNA flu vaccine or an approved seasonal flu vaccine 
• Will receive compensation for study-related time 
• Do not need insurance to join this study 

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you. 

You can talk to a Meridian enrollment specialist about this study by calling (712) 639-6200 (Norfolk) or (402) 934-7563 (Omaha).